GAEU supports BrainCool in securing €12.5M from the European Investment Bank (EIB)
GAEU Consulting supports BrainCool AB (publ) in securing EUR 12.5 million in Venture Debt Financing from the European Investment Bank (EIB)
BrainCool AB, an innovative leader in medical device technology, has successfully secured 12.5 million euros in venture debt financing from the European Investment Bank (EIB). This substantial loan agreement not only underscores the high potential of BrainCool and its technology but also ensures long-term financial support for its products soon to be introduced to the market. GAEU Consulting played a pivotal role as a strategic project advisor in facilitating this process.
Martin Waleij, CEO of BrainCool, comments: "The loan agreement with EIB further validates BrainCool’s cutting-edge technology, underpinning our goal to become a major player in the medical device market. This agreement supports our ambitious plan to develop an extensive clinical pipeline of groundbreaking therapies, initially focusing on stroke, then expanding to sudden cardiac arrest and oncology. Throughout this process, GAEU Consulting has offered invaluable support, including strategic project advice, assistance during due diligence, and financial modelling expertise. We strongly recommend GAEU as a highly experienced EIB advisor."
Tomasz Wąsik, MBA, CEO of GAEU Consulting Horizon Europe Centre of Excellence, comments: "We are very pleased to end another great year at GAEU with such a significant project. The European Investment Bank (EIB) plays a big role in supporting innovation in Europe, and we believe many other companies could also benefit from what the EIB offers. Our team is well-equipped to help our clients work through the EIB's processes, which need good financial knowledge and a clear understanding of what the EIB requires. We want to thank everyone at BrainCool for their excellent cooperation on this project.”
The EIB's venture debt product addresses the unique funding needs of fast-growing innovative companies. The financing structure includes bullet repayment and remuneration linked to the equity risk of the investees, complementing existing venture capital financing. Read more on: www.eib.org
BrainCool AB (publ) is an innovative medical device company that develops, markets, and sells leading medical cooling systems for indications and areas with significant medical benefits within the healthcare sector. BrainCool AB (publ) is based in Lund, Sweden, and its share is listed on Nasdaq First North Growth Market, named “BRAIN”. More information can be found at www.braincool.se.
GAEU Consulting is a professional consulting firm specializing in advising innovative companies on securing EU funding and raising private capital for projects and growth activities. For more information, visit www.gaeu.com.
